HR Execs on the Move

Infinity Laboratories

www.infinitylaboratories.com

 
Infinity Laboratories was founded in 1991 on the bedrock principles of excellence, integrity, and quality. Today, the Company is a national chemical and microbiological testing laboratory servicing the medical device and pharmaceutical industries. Infinity Labs was recently named one of Colorado`s top innovative companies by the nonprofit Colorado Companies to Watch honors 50 firms each year for their innovative work. Infinity Laboratories was chosen out of a field of more than 1,000 Colorado companies.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

VIRCO Lab

VIRCO Lab is a Bridgewater, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Uhrich Michael

Uhrich Michael is a Euclid, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

INBIOS Intl

INBIOS Intl is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Enviro Matrix Analytical Inc

Enviro Matrix Analytical Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Natera

Natera Inc. is a genetic testing company that specializes in analyzing tiny quantities of DNA for reproductive health. Natera operates a CLIA-certified laboratory in San Carlos, Calif., providing a host of preconception and prenatal genetic testing services. Test offerings include pre-implantation genetic diagnosis to identify chromosomal anomalies or inherited genetic conditions in embryos generated during an IVF cycle; products-of-conception testing following miscarriage to analyze fetal chromosomes and understand the cause of the pregnancy loss; non-invasive prenatal testing to determine paternity; carrier screening to detect whether parents carry genetic variations that may result in disease in the child; and Panorama, a safe, simple test for pregnant women that identifies the most common chromosomal anomalies in a fetus as early as nine weeks of gestation. Natera's PreNATUS clinical trial for non-invasive screening of fetal chromosomal anomalies is funded by the NIH and is being conducted by the leaders in maternal-fetal medicine in the United States. These tests were developed by Natera, a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). They have not been cleared or approved by the U.S. Food and Drug Administration (FDA). In August, Natera was selected by the World Economic Forum as a Technology Pioneer for innovations in prenatal care. For more information, visit www.natera.com.